Outcomes | Group type | Pvaluea | |
---|---|---|---|
Control | Intervention | ||
N = 111 | N = 120 | ||
Third month monitoring | |||
Self-reported 4-week point prevalence abstinence | 0.049 | ||
Yes | 49 (44.1%) | 69 (57.5%) | |
No | 62 (55.9%) | 51 (42.5%) | |
Breath CO level | 7.75 ± 3.9 | 7.24 ± 3.6 | 0.334b |
Smoking status (verified) | 0.144 | ||
Non smoker | 41 (36.9%) | 56 (46.7%) | |
Smoker | 70 (63.1%) | 64 (53.3%) | |
Sixth month monitoring | |||
Self-reported 4-week point prevalence abstinence | < 0.001 | ||
Yes | 57 (51.4%) | 89 (74.2%) | |
No | 54 (48.6%) | 31 (25.8%) | |
Breath CO level | 7.12 ± 4.3 | 5.73 ± 3.5 | 0.005b |
Smoking status (verified) | < 0.001 | ||
Non smoker | 54 (48.6%) | 86 (71.7%) | |
Smoker | 57 (51.4%) | 34 (28.3%) |